Introduction
Most neonates with necrotizing enterocolitis (NEC) can be successfully treated with intensive medical and/or surgical care. [1] [2] [3] [4] However, a minority of cases are fulminating and rapidly fatal, with massive necrosis of the bowel seen at laparotomy or autopsy. Relatively few published reports have focused on these fulminant cases. [5] [6] [7] [8] [9] It is not clear whether fulminant NEC constitutes a distinct sub-category of NEC with unique characteristics and pathogenic features, or alternatively, whether this is part of the NEC spectrum with the same pathogenesis as milder cases. We hypothesized that fulminant NEC could be more clearly defined using the large data marts of Intermountain Healthcare. To accomplish this, we identified all fulminant NEC cases in the past 9 years (our present electronic data bases were introduced in 2001) and analyzed their characteristics using case-control methodologies.
Methods
The study involved patients cared for at any Intermountain Healthcare hospital with a date of birth during the 9-year period, 1 January 2001 to 31 December 2009. The Intermountain Healthcare Institutional Review Board and the University of Utah Institutional Review Board approved the study as a data-only investigation using deidentified information and not requiring written informed consent.
The diagnoses of 'NEC' plus 'death' were ascertained from electronic data marts; Case Mix, Salt Lake City, UT, USA (the billing, coding and financial data mart used by Intermountain Healthcare), EVOX (the extended Vermont-Oxford database, VO Network, Burlington, VT, USA) and ICD9. The electronic medical record was used to verify the diagnoses of NEC and death, using the surgical and pathological reports and death summaries. The electronic medical record is a modified subsystem of Clinical Workstation. The 3M Company (Minneapolis, MN, USA) approved the structure and definitions of all data points for use within the electronic medical record program, and data were managed and accessed by authorized data analysts only.
The medical records (electronic information plus paper charts) of each neonate identified with NEC and death were examined by two or more of the authors. All radiographic images, radiographic reports, physician's notes and nursing notes pertinent to NEC and death were reviewed. To document the occurrence of NEC, we used the criteria originally proposed by Bell et al., 10 as subsequently modified by Walsh and Kliegman, 11 and adopted by the Vermont Oxford Network.
12 This definition required the presence of one or more of the following three clinical signs: (1) bilious gastric aspirate or emesis, (2) abdominal distension and (3) occult or gross blood in stool (no fissure), and one or more of the following three radiographic findings: (1) pneumatosis intestinalis, (2) hepato-biliary gas and (3) pneumoperitoneum. Patients were not included in this study if they had focal intestinal perforation or a condition other than NEC (such as intestinal volvulus). 13 'Fulminant NEC' was defined as a death ascribed to NEC, with the period between diagnosis of NEC and death of less than 48 h.
Blood samples were run on a Hematology Analyzer (Beckman Coulter; Fullerton, CA, USA) at all Intermountain Healthcare facilities except Primary Children's Medical Center, which utilized a Hematology Analyzer (Sysmex; Mundelein, IL, USA). The immature to total (I/T) neutrophil ratio was calculated by dividing the percent metamyelocytes, plus band neutrophils on the manual differential cell count, by the percent metamyelocytes, plus band neutrophils plus segmented neutrophils. 14 For the case-control studies, each patient with fulminant NEC was matched with two control patients with non-fulminant NEC. Cases and controls were matched by all of the following: (1) gestational age at birth ( ± 2 weeks), (2) birth weight ( ± 0.5 kg), (3) gender, (4) mother's race (white vs non-white) and (5) mother's age at delivery (<18 years vs X18 years). An additional control group consisted of neonates who did not develop NEC, but were matched with the fulminant cases on the bases of the demographic features above.
The Table 1 individually for each of the five largest NICUs in the state of Utah.
Demographic features of the neonates with fulminant NEC, the matched non-fulminant NEC controls and the matched no-NEC controls are shown in Table 2 . The matching appeared adequate, because no differences were found between cases and either control group in the features for which matching was performed. The group of 35 with fulminant NEC had lower birth weights (1089±545 vs 1652±817 g, P ¼ 0.000) and earlier gestational ages (27.5 ± 3.4 vs 31.1 ± 4.4 weeks, P ¼ 0.000) than the group of 488 with non-fulminant NEC. 
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Three of the 35 fulminant cases died with acidosis and hypotension before surgery could be performed. Laparotomy was performed in 29 and peritoneal tap and drainage in three. In 29 cases, 27 were judged to have NEC totalis. All 32 that died within hours following surgery had refractory acidosis and hypotension and were judged to have extensive bowel disease incompatible with life. Four of the non-fulminant NEC cases died; all four had a laparotomy with bowel resection and died several days to weeks later. Details of the radiographs and surgical features are shown in Table 3 . Portal venous air was observed in 57% of the fulminant cases and in 16% of the non-fulminant cases (P ¼ 0.000).
No differences were observed between fulminant and nonfulminant cases in early onset sepsis or placental abruption. Detection of a positive blood culture within 72 h before diagnosis of NEC was not significantly different between fulminant and nonfulminant NEC (details are shown in Supplementary Material #1). Fulminant cases were not more likely to be receiving oral caffeine citrate at the time NEC was diagnosed (27% were, vs 21% of those who developed non-fulminant NEC, and 21% of those who did not develop NEC). However, fulminant cases were more likely to have had an increase in human milk fortifier in the 48 h period preceding NEC diagnosis (Table 4 ). In fact, 10 of the 35 (29%) with fulminant NEC had fortifier added to X24 calories/oz during this period, compared with 10 of the 70 (14%) who developed non-fulminant NEC (P ¼ 0.110), and compared with 7 of the 70 (10%) who did not develop NEC (P ¼ 0.020 vs fulminant NEC). In 35 fulminant cases, 16 had enteral feedings increased from 0 to 120 ml/kg/day in 6 days or less, compared with 13 of 70 with non-fulminant NEC (P ¼ 0.003). Red blood cell transfusions were more commonly administered during this 48 h period to those who subsequently developed fulminant and non-fulminant NEC, compared with those who did not develop NEC (P ¼ 0.004).
Hematocrits were obtained during the 24 h before NEC in 28 of the 35 with fulminant NEC, in 42 of 70 with non-fulminant NEC and in 18 of 70 with no NEC (Supplementary Material #2) . As a group, those who went on to develop fulminant NEC had lower hematocrits (P<0.01). In fact, the four lowest hematocrits measured were all from those who subsequently developed fulminant NEC.
In the 72 h preceding NEC diagnosis, those who went on to fulminant NEC had lower blood lymphocyte counts (3413 ± 1505/ml) than those who developed non-fulminant NEC (5733±2493/ml, P ¼ 0.000). The group with no NEC had lymphocyte counts of 4445±2157/ml (P ¼ 0.018 vs non-fulminant). Five of those with fulminant NEC had a blood neutrophil count lower than any of the no-NEC controls. Five with non-fulminant NEC had a blood neutrophil count above and two below the range of the no-NEC controls (Supplementary Material #3). I/T neutrophil ratios were higher in those with fulminant NEC (0.55±0.30) than in those with non-fulminant NEC (0.34 ± 0.28, P ¼ 0.008 vs fulminant) and those who did not develop NEC (0.14±0.17, P ¼ 0.000 vs fulminant). Clinical and laboratory features that were more common with fulminant than non-fulminant NEC are shown in Table 5 .
Discussion
In this series, about 7% of neonates who developed NEC had a rapidly fatal course. [5] [6] [7] [8] [9] The annual number of such cases in our health system seems to be a relatively constant proportion of the total number of NEC cases. In a previous report of NEC cases between the years 2002 and 2005, we noted that NEC prevalence varied considerably from one NICU to another, even within the same state. 16 The present report indicates that this variability also exists for fulminant cases.
NEC does not arise from a single pathogenic entity, but is a phenotype that can come from several different pathways. 17, 18 This also seems to be the case for the fulminant variety. Among 105 neonates in this study who developed NEC, the most significant associations with fulminant NEC were lower birth weight and lower gestational age. When these features were corrected for using case-control matching, we found no single association or antecedent common to all who developed fulminant NEC. For example, four of the 35 had a hematocrit <22%. However, the other 31 fulminant cases had hematocrits in the same range as the controls. Therefore, perhaps anemia was relevant to the pathogenesis in some cases, but in the majority it apparently was not. Erythrocyte transfusion was not more common among the fulminant versus non-fulminant cases, yet as we previously 19 transfusions were much more common just before developing NEC (both fulminant and non-fulminant cases) compared with the no-NEC controls.
The radiographic finding of portal venous air was more common in those who went on to a fulminant course. It was seldom clear preoperatively whether this finding indicated a larger segment of initial bowel involvement when compared with non-fulminant NEC, or was the result of diffuse intestinal compromise of mucosal integrity due to a specific pathogen or toxin. 20 Indeed, this question is central to understanding fulminant NEC, but remains to be answered.
Within 48 h before developing NEC, the concentration of human milk fortifier was increased in half of those who developed fulminant NEC versus 27% of those who developed non-fulminant NEC. We were unable to determine whether this was predominantly with one variety of human milk fortifier, as this information was not recorded. Hammond et al. 9 reported nine cases of fulminant NEC, where a change in formula preceded the NEC diagnosis. The most common change in that report was a switch from human milk to bovine formula. We previously identified rapid escalation of feeding volume as contributing to early-onset NEC. 21 In the present report, more cases in the fulminant group had feedings increased from 0 to 120 ml kg À1 per day in a period of 6 days or fewer (an average increase of >20 ml kg À1 per day) preceding development of NEC. Beyond the elements of increasing fortifier and rapid escalation of feeding volumes, we were unable to determine whether any specific feeding regimen was associated with fulminant NEC, because no NICU had a feeding regimen that was consistent over this entire 9-year period, and regimens changed frequently among the various NICUs during this interval.
We observed lower lymphocyte counts and higher I/T neutrophil ratios among those with fulminant NEC, supporting the concept of infectious involvement in the process. We speculate that reduced bowel perfusion accompanying bacterial overgrowth and translocation might have pathogenic features in the bowel that are similar to those accompanying severe anemia, such as reduced oxygen delivery to gastrointestinal issues. 22 The rapid onset and quick death with fulminant NEC can be extremely difficult for families and for the medical caregivers. Certainly, there is a need to reduce the number of these cases. Retrospective studies, such as the present, rarely identify a clear strategy for so doing, but they sometimes stimulate the generation of new hypotheses. As fulminant NEC is uncommon, prevention strategies will be difficult to test. Perhaps, as part of future attempts to do so, the following questions could be considered: (1) Is portal air as a first radiographic sign a hallmark of fulminant NEC? (2) Can we devise feeding plans that minimize feeding fortification and escalation during peak windows of NEC risk? (3) Are there patterns in the complete blood count at the time of NEC diagnosis that has reliable prognostic value?
